Figure 6.
(a) Amplification of kinetic curves of OPG mRNA expression; (b) amplification of kinetic curves of GAPDH mRNA expression; (c) comparison of OPG mRNA expression in the control to that of the treatment group at 1, 3 days, 1, 2, 4, 6, and 8 weeks after roughly focused ESWT. OPG mRNA expression in the treatment group and in the control group, P < 0.05 (data not shown) (note: BMP-2 mRNA expression at 1 day after roughly focused ESWT was normalized to 1). BMP-2: Bone morphogenetic protein-2; OPG: Osteoprotegerin; mRNA: Messenger RNA; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; ESWT: Extracorporeal shock waves therapy.